JESSICA LAW: Open Payments
NPI 1326594847 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,023 in 95 payments from 25 companies in 2025. Trend: 2023 $2,234 · 2024 $2,110 · 2025 $2,023
Food & beverage: $2,003Education: $20
| Company | Payments | Amount |
|---|---|---|
| Genmab U.S., Inc. | 12 | $270 |
| Merck Sharp & Dohme LLC | 13 | $261 |
| ABBVIE INC. | 11 | $170 |
| Janssen Biotech, Inc. | 8 | $162 |
| Syndax Pharmaceuticals, Inc. | 6 | $156 |
| Novartis Pharmaceuticals Corporation | 4 | $95 |
| PFIZER INC. | 5 | $92 |
| Genentech USA, Inc. | 4 | $85 |
| GENZYME CORPORATION | 3 | $82 |
| Daiichi Sankyo Inc. | 3 | $72 |
Products named: KEYTRUDA, EPKINLY, VENCLEXTA, AYVAKIT, KISQALI, ELREXFIO, CARVYKTI, Trodelvy.
Industry payments across KY — which companies pay providers there.
